The report contains a comprehensive analysis of the global market along with the study of the regional markets.
This latest research report Human Growth Hormone Market (Hgh) analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have being profiled along with their key financials and strategies for growth.
Human growth hormone is produced by the pituitary gland and it spurs growth in children and adults.
It regulates body fluids, muscle and bone growth and fat metabolism of the body. Growth hormone is important for normal functioning in humans.
The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD) and it can be tackled by administering intramuscular or subcutaneous GH injections on daily basis.
Report: www.marketreportsonline.com/contact…ame=737798.
In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD.
The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.
The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting hGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.
Key Company Coverage: Novartis AG, Pfizer Inc., Eli Lilly and Company & Novo Nordisk A/S
Complete report on Human Growth Hormone (Hgh) Market spread across 86 pages with providing 4 company profiles, 10 table and 41 charts is now available at www.marketreportsonline.com/737798.html.
Few Points from List of Tables:
The US Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2023)
EU Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2023)
Japan Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2020-2023)
The US & ROW Pediatric & Adult Growth Hormone Deficiency Market of TransCon hGH (2020-2023)
Long-Acting hGH Formulations in Development Globally (2017)
Average Annual Cost of hGH Therapy for Children and Adults
Pediatric GHD Phase III Trial Design with Long-Acting hGH Formulations (2017)
Adult GHD Phase III Trial Design with Long-Acting hGH Formulations (2017)
Project Pipeline in Various Stages of R&D (2017)
New Products of Novo Nordisk A/S in Pipeline (2017)
News From
MarketReportsOnline Category: Industry Reports & Market Analysis Profile: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
